Friday, April 05, 2013 6:02:26 PM
In conclusion, we believe that results from this in vitro study should be carefully reviewed and interpreted, but one conclusion is clear, MANF appears to be neuroprotective against both NMDA-mediated necrosis induction and STS-mediated apoptosis induction in vitro. These results are consistent with previously executed experiment and support further testing in an in vivo model to confirm whether these events translate into a more complex organismal system/pre-clinical model. This is certainly an exciting compound that deserves further investigation to identify not only molecular mechanisms of action but also potential clinical applications.
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM